Clinical trial
Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis Among Patients Undergoing Carpal Tunnel Release Surgery - A Prospective Study
NCT04276220 is registered in ClinicalTrials.gov with Steen Hvitfeldt Poulsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis Among Patients Undergoing Carpal Tunnel Release Surgery - A Prospective Study
- Lead sponsor
- Steen Hvitfeldt Poulsen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2020
- Completion date
- May 21, 2025
- Enrollment
- 109 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
transthyretin amyloidosis, transthyretin cardiac amyloidosis, wild-type transthyretin-related (attr)amyloidosis